Theorem Clinical Research Expands Partnership with Medidata Solutions
Theorem Clinical Research recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.
Theorem Clinical Research, a contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.
This accreditation enables Theorem to provide a unified approach to capture data directly from patients. Clinical investigators and sponsors will gain operational efficiencies with immediate access to review electronic patient reported outcomes (ePRO) data in one platform while leveraging Theorem’s clinical expertise.
“We will be able to transform what can be a lengthy and expensive process into a fast implementation using Medidata’s platform of cloud-based solutions, which includes capabilities to facilitate direct communication with patients,” said Mark Penniston, executive vice president and general manager for clinical analytics.
“Theorem shares our vision of bringing the voice of the patient into clinical research and positively transforming the clinical trial experience for all study participants,” said Steve Heath, Medidata’s vice president of channel sales. “This accreditation reinforces Theorem’s commitment to leveraging innovative technology to accelerate the delivery of medicine to patients around the world.”
Theorem has built hundreds of studies in Medidata Rave and is a top holder of accreditations among Medidata Services Partners with accreditation in:
- Medidata Rave
- Medidata Rave Safety Gateway
- Medidata Rave Targeted SDV
- Medidata BalanceRandomization
Theorem clinical analytics experts will deliver two presentations during the
Medidata Symposium 2014
April 23–25 in San Francisco:
- Impact Analysis – Key Considerations Before Making Post-Production Changes, presented by April Bebee and Beatrice Clark
- Targeted SDV (TSDV) Lessons Learned, presented by Vicken Yanikian
Additionally, innovative solutions will be featured during the symposium in the Innovation Lounge, including automation of mapping from Medidata Rave into CDISC-compliant data sets via SAS CDI and real-time data visualizations from Medidata Rave to Spotfire visual analytics.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
